Oropep 2.250 Injection
Marketer
Rishab Healthcare pvt. Ltd.
Salt Composition
Piperacillin (2000mg) + Tazobactum (250mg)
Overview Oropep 2.250 Injection
Combiflox 2.250 Injection combines two antibiotics to combat diverse bacterial infections by eliminating the infectious microorganisms. Administration should always be performed by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined by your physician, based on the severity of your condition, and must adhere to their prescribed regimen. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, inform your physician of any antibiotic allergies, kidney or liver impairments. Dosage adjustments or alternative medications may be necessary. While generally safe under medical guidance, its use during pregnancy and lactation requires physician oversight.
Primary Ingredients of Oropep 2.250 Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Oropep 2.250 Injection
Infections caused by bacteria
Major Benefits of Oropep 2.250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Oropep 2.250 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Oropep 2.250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Oropep 2.250 Injection works:
Oropep 2.250 Injection combines piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby improving piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Oropep 2.250 Injection use.
PregnancySAFE IF PRESCRIBED
The administration of Oropep 2.250 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely use Oropep 2.250 Injection. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Oropep 2.250 Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Oropep 2.250 Injection with careful monitoring. Dosage modification for Oropep 2.250 Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Oropep 2.250 Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Oropep 2.250 Injection :
Omitting a scheduled Oropep 2.250 Injection dose requires contacting your physician.
Facts to Know About Oropep 2.250 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently